NEW YORK, NY / ACCESSWIRE / February 16, 2016 / Today's pre-market action directs our attention to healthcare and a few names we have covered previously. Given the broad decline we see opportunity in select companies with clever trade setups designed to benefit from short-terms swings. We see a distinct pattern and this morning we have alerted our members to consider these stocks. One name in particular may outperform the entire sector by a lengthy margin. You would not want to miss this potential billion dollar money maker! Click here:
http://valuableinvestment.com/FreeAlert
Outperform the market and learn trade strategies today by signing up here:
At ValuableInvestment.com, stock investors can easily increase their portfolio, as our team of professionals is always providing information that matters to you and trade patterns that allow our members to realize a significant return on their investment. Aside from this, members also get instant access to more than 500 company reports. Take a moment to enter your email for your free daily alerts at:
ValuableInvestment.com trade alerts have been initiated on these healthcare stocks: Cempra Inc. (NASDAQ: CEMP), Dynavax Technologies Corporation (NASDAQ: DVAX), INSYS Therapeutics (NASDAQ: INSY), and Radius Health Inc. (NASDAQ: RDUS). Know which stocks are producing triple digit returns this month by clicking on this link below:
http://valuableinvestment.com/alerts
On Friday, February 12, 2016, the NASDAQ Composite ended the day at 4,337.51, up 1.66%, the Dow Jones Industrial Average climbed 2.00%, to finish at 15,973.84, and the S&P 500 closed 1.95% higher at 1,864.78. Register for your complimentary reports at:
http://valuableinvestment.com/signup
Cempra Inc.'s stock rose 0.18%, to close the day at $16.56. The stock recorded a trading volume of 624,624 shares, below its three months average volume of 933,660 shares. The company's shares are trading 32.06% below their 50-day moving average. Additionally, Cempra has a Relative Strength Index (RSI) of 33.30. Sign up and access the free trade alerts on CEMP at:
http://valuableinvestment.com/CEMP
On Friday, shares in Dynavax Technologies Corporation ended the session 0.32% higher at $18.97. The stock reported a trading volume of 707,061 shares, below its three months average volume of 1.00 million shares. The company is trading 22.24% below its 50-day moving average. Moreover, shares of Dynavax Technologies Corporation have an RSI of 37.32. The trade alert on DVAX is available for free at:
http://valuableinvestment.com/DVAX
INSYS Therapeutics Inc.'s stock closed the day 1.68% higher at $16.99. A total of 531,542 shares were traded, which was below its three months average volume of 918,830 shares. The company's shares are trading below their 50-day moving average by 30.40%. Additionally, INSYS Therapeutics has an RSI of 34.43. Register for free on ValuableInvestment.com and access the latest trade alert on INSY at:
http://valuableinvestment.com/MUR
On Friday, shares in Radius Health Inc. recorded a trading volume of 1.13 million shares, above its three months average volume of 928,780 shares. The stock ended the day 3.06% higher at $26.97. The company is trading below its 50-day moving average by 42.83%. Furthermore, Radius Health has an RSI of 29.76. The complimentary alerts on RDUS can be activated at:
http://valuableinvestment.com/RDUS
About ValuableInvestment.com:
Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.
NO WARRANTY
ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://valuableinvestment.com/
RESTRICTIONS
ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press@valuableinvestment.com
SOURCE: ValuableInvestment.com
